CLINICAL_TRIALS
trial_result
· 2025-10-21
Clinical Trial Update: A Study of Colesevelam for Lenalidomide-Associated Diarrhea [Phase 2]
Summary
A Phase 2 study evaluating colesevelam for lenalidomide-associated diarrhea in multiple myeloma patients has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma, Diarrhea | Phase 2 | Status: COMPLETED | Results posted: 2025-10-21